Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke–Enhanced Regimen Stroke Trial

Overview of attention for article published in Stroke, July 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 7 news outlets

twitter: 2 X users

Readers on

mendeley: 79 Mendeley

So far, Altmetric has seen 7 news stories from 7 outlets.

Study shows combination stroke therapy safe and effective

Medical News Today, 01 Aug 2013

The combination of the clot-busting drug tPA with an infusion of the antiplatelet drug eptifibatide dissolves blood clots…

Combo Stroke Tx Safe, Effective

ThirdAge, 31 Jul 2013

The combination of the clot-busting drug tPA with an infusion of the antiplatelet drug eptifibatide dissolves blood clots…

Combination of tPA with infusion of antiplatelet drug dissolves blood clots safely

The Medical News, 31 Jul 2013

The combination of the clot-busting drug tPA with an infusion of the antiplatelet drug eptifibatide dissolves blood clots…

Study shows combination stroke therapy safe and effective

MedicalXpress, 30 Jul 2013

The combination of the clot-busting drug tPA with an infusion of the antiplatelet drug eptifibatide dissolves blood clots…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 3 additional news stories.